Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT04535869
Eligibility Criteria:
Inclusion Criteria:
* All cases positive for COVID-19
* Male and non-pregnant female patients,
* 18 years of age or older,
* All moderate and severe caseswith pneuomnia.
Exclusion Criteria:
* Known allergy or hypersensitivity to the used medications
* Known severe liver disease
* Use of medications that are contraindicated with the trial medications and that could not be replaced or stopped during the trial period
* Pregnancy or breast-feeding or known active HCV infection, because of concerns about the development of resistance
* History of bone marrow transplant
* Known G6PD deficiency
* Chronic hemodialysis or Glomerular Filtration Rate \< 20ml/min
* Psoriasis
* Porphyria
* Concomitant use of digitalis, flecainide, amiodarone, procainamide, or propafenone
* Known history of long QT syndrome
* Current known QTc\>500 msec
* Pregnant or nursing
* Weight \< 35kg
* Seizure disorder
* Patients receiving Amiodarone.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04535869
Study Brief:
Protocol Section:
NCT04535869